CompoAtlas

PEAU

Food supplement declared in France, declaration No 2024-4-615, decision dated 11 April 2024

PEAU is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
CBLR PARTENAIRES
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
2 gélules par jours
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes, Insuffisance rénale
Objectives stated by the manufacturer (these are not authorised claims)
Peau, Cheveux et ongles

Declaration 322691, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Arctium lappa L.RacineExtrait sec aqueux300 mg
Urtica dioica L.Parties aériennesExtrait sec aqueux300 mg
Equisetum arvense L.Parties aériennesExtrait sec aqueux120 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Acétate de rétinyleVitamine A3,000 µg d'équivalent rétinol800 µg
Bisglycinate de zincZinc25 mg15 mg

Additives

E464

Other ingredients

Bambusa bambos (L.) Voss

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2024. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé en cas d’allergie croisée connue, en particulier aux plantes de la famille des Asteraceae. Déconseillé en cas de traitement concomitant par un médicament diurétique. Déconseillé en cas d’insuffisance cardiaque. Déconseillé aux femmes ménopausées.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.

List recorded in 2024. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line